This workshop will give participants an overview of opioid treatment history in the United States, changes in laws regarding the treatment of opioid addiction and the implications for the treatment system, and the type of medication used to treat opioid addition disorders. Participants will learn critical information about opioid use and treatment including how to achieve a diagnosis, determine which medication would be most effective, and develop links between substance abuse treatment providers and physicians authorized to prescribe treatment medication
1. Identify groups of people using opioids
2. Define the components of the patient selection process
3. Identify the role of addiction programs and professionals in providing buprenorphine treatment
4. Identify key issues in coordinating care, including other professionals who play a role in the continuum of care
5. State recovery strategies effective in opioid recovery including dealing with cravings and triggers, treatment approaches with special populations, and medication-assisted patient management issues
This class has been submitted for approval for the following credits: 6.0 hours by NH-NASW, 6.0 NBCC contact hours, and 6.0 CE hours for MLADC Category of Competence 13, 14, 18.
About the Presenter
Mike Gaudet, LICSW
Michael Gaudet earned his undergraduate degree in 1981 at Bridgewater State College and his MSW from Rhode Island College in 1984. He is currently the Director of Quality Assurance for eleven outpatient mental health and substance abuse programs in Massachusetts, with a primary office at Arbour Counseling Services, Fall River, MA. In addition, he serves as the organization’s Compliance and Privacy Officer and is a surveyor for CARF International. Mike has extensive clinical and supervision experience in mental health and substance abuse treatment. He trains and consults across the country on clinical and professional growth topics, and, since 1986, is a faculty member of the New England Institute of Addiction Studies. He has been involved in several projects designed to advance the use of medication in substance abuse recovery, including the use of Methadone, Buprenorphine and Naltrexone, through the Addiction Technology Transfer Center of New England.